| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.17 | 6e-08 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.19 | 8e-08 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-07 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |